Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical trial

INTRODUCTION: Proliferative diabetic retinopathy (PDR) is the main cause of severe visual loss in people with diabetes mellitus. The standard treatment for this condition is panretinal photocoagulation (PRP). This laser treatment is inherently destructive, with predictable adverse effects on visual...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open
Main Authors: Sivaprasad, Sobha, Prevost, A Toby, Bainbridge, James, Edwards, Rhiannon Tudor, Hopkins, David, Kelly, Joanna, Luthert, Phil, Murphy, Caroline, Ramu, Jayashree, Sarafraz-Shekary, Negin, Vasconcelos, Joana, White-Alao, Beverley, Hykin, Philip
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2015
Assuntos:
Ophthalmology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4577925/
https://ncbi.nlm.nih.gov/pubmed/26369798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2015-008405
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados